Expressing the sense of Congress about the Food and Drug Administration proposal to designate the use of chlorofluorocarbons in metered-dose inhalers as non-essential.

Expresses the sense of the Congress that: (1) a specified proposed Food and Drug Administration (FDA) regulation to designate the use of chlorofluorocarbons (CFCs) in metered-dose inhalers (MDIs) as nonessential so as to make MDIs using CFCs adulterated devices puts at risk the health of millions of asthma patients and does not contribute measurably to protection of the environment; and (2) the FDA should withdraw its proposal and focus its efforts on implementing existing Montreal Protocol decisions that will facilitate a transition to CFC-free MDIs by 2005.